- Previous Close
0.0000 - Open
1.7500 - Bid --
- Ask --
- Day's Range
1.7500 - 1.7500 - 52 Week Range
1.6800 - 2.5000 - Volume
101 - Avg. Volume
16 - Market Cap (intraday)
27.005M - Beta (5Y Monthly) -0.22
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 29, 2024
- 1y Target Est
--
Dynasil Corporation of America develops, markets, manufactures, and sells detection, sensing, and analysis technology and optical components in the United States, Asia, Europe, and internationally. It operates through Optics, Innovation and Development, and Biomedical segments. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used in devices, such as baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, automotive components, semiconductor/electronic devices, spacecraft/aircraft components, and advertising displays in the medical, industrial, and homeland security/defense sectors. The Innovation and Development segment develops advanced technology in materials, sensors, and prototype instruments that detect or measure radiation, light, magnetism, or sound for use in security, medical, and industrial applications. The Biomedical segment engages in the development of tissue sealant products. The company distributes its products through direct sales and marketing staff, as well as through manufacturer's representatives and distributors. Dynasil Corporation of America was founded in 1960 and is headquartered in Newton, Massachusetts.
www.dynasil.com207
Full Time Employees
September 30
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: DYSL
View MorePerformance Overview: DYSL
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DYSL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DYSL
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.85%
Return on Assets (ttm)
0.02%
Return on Equity (ttm)
-1.91%
Revenue (ttm)
43.7M
Net Income Avi to Common (ttm)
-370k
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
268k
Total Debt/Equity (mrq)
32.11%
Levered Free Cash Flow (ttm)
-1.32M